ReviewTherapeutics and clinical risk management2016

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

Kimberly D Leuthner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.